|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 253.02 USD | -1.52% |
|
+2.86% | -0.27% |
| 05/12 | Sector Update: Health Care Stocks Slide Late Afternoon | MT |
| 05/12 | Humana Exploring Pharmacy Partnership With Mark Cuban | MT |
Business description: Humana Inc.
- health insurance services (95.2%): to recipients of government-sponsored plans, to groups of employers and individuals;
- services (3.8%): health care, primary care, home clinical care, health coaching services, prescription of drugs, pharmaceutical services, etc.;
- other (1%).
Number of employees: 65,680
Sales by Activity: Humana Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Insurance | - | - | - | 10TCr | 11TCr |
Retail (Excl. Individual Commercial) | 6.73TCr | 7.4TCr | 8.25TCr | - | - |
Group and Specialty | 728.5Cr | 687.2Cr | 631.4Cr | - | - |
Centerwell | - | - | - | 1.84TCr | 1.99TCr |
Healthcare Services | 2.84TCr | 3.12TCr | 3.53TCr | - | - |
Eliminations/Corporate | -2.59TCr | -2.96TCr | -3.12TCr | -1.49TCr | -1.59TCr |
Geographical breakdown of sales: Humana Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
United States | 7.72TCr | 8.42TCr | 9.29TCr | 11TCr | 12TCr |
Executive Committee: Humana Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
James Rechtin
CEO | Chief Executive Officer | 54 | 01/07/2024 |
Celeste Brown
DFI | Director of Finance/CFO | 48 | 11/01/2025 |
Japan Mehta
CTO | Chief Tech/Sci/R&D Officer | 44 | 01/02/2025 |
| Chief Tech/Sci/R&D Officer | 56 | 01/01/2020 | |
Lisa Stoner
IRC | Investor Relations Contact | - | 01/08/2021 |
Composition of the Board of Directors: Humana Inc.
| Director | Title | Age | Since |
|---|---|---|---|
Kurt Hilzinger
CHM | Chairman | 64 | 01/01/2014 |
Frank D'Amelio
BRD | Director/Board Member | 67 | 01/09/2003 |
Karen Katz
BRD | Director/Board Member | 68 | 23/09/2019 |
Wayne Frederick
BRD | Director/Board Member | 53 | 20/02/2020 |
John Garratt
BRD | Director/Board Member | 56 | 20/02/2020 |
Bono Raquel Cruz
BRD | Director/Board Member | 68 | 04/09/2020 |
Marcy Klevorn
BRD | Director/Board Member | 65 | 17/02/2021 |
Jorge Mesquita
BRD | Director/Board Member | 63 | 17/02/2021 |
David Feinberg
BRD | Director/Board Member | 62 | 01/03/2022 |
Brad Smith
BRD | Director/Board Member | 61 | 01/09/2022 |
Company details: Humana Inc.

Other Managed Healthcare
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.52% | +2.86% | -12.17% | -53.73% | 3.04TCr | ||
| -1.83% | +1.15% | -45.40% | -37.80% | 30TCr | ||
| +0.83% | -1.49% | -16.65% | -36.31% | 7.41TCr | ||
| -0.70% | -3.57% | -18.69% | -17.96% | 7.17TCr | ||
| +0.10% | -1.55% | -35.00% | -54.72% | 1.91TCr | ||
| +0.99% | +1.51% | -51.48% | -54.94% | 773.93Cr | ||
| +1.57% | +0.94% | +54.95% | +50.39% | 388.18Cr | ||
| -1.63% | -9.55% | +62.30% | -30.38% | 208.2Cr | ||
| +1.53% | +8.57% | -22.45% | +95.59% | 137.44Cr | ||
| +1.08% | -3.38% | -20.38% | - | 39Cr | ||
| Average | +0.30% | -0.20% | -10.50% | -15.54% | 5.13TCr | |
| Weighted average by Cap. | +0.43% | +0.09% | -33.97% | -35.59% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HUM Stock
- Company Humana Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















